Bexarotene Capsule, Liquid Filled
Product Images NDC 0378-6955

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 0378-6955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bexarotene Capsules 75 mg Bottle Label (Image 01)

Bexarotene Capsules 75 mg liquid-filled oval capsules with imprint B75 shown. The label includes dosage strength and instructions for pharmacists to dispense patient information leaflets. Manufactured by Patheon Softgels, Inc. and labeled by Mylan Pharmaceuticals Inc. The package contains 100 capsules.*

FDA Label Image

Bexarotene Structural Formula (Image 02)

Chemical structure of bexarotene, showing its molecular framework with multiple rings, methyl groups, and a carboxylic acid functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.